Apixaban exerts anti-inflammatory effects in mesangial cells by blocking thrombin/protease-activated receptor-1 system

被引：17

作者：

Ishibashi, Yuji ^{[1
]}

Matsui, Takanori ^{[1
]}

Yamagishi, Sho-ichi ^{[1
]}

机构：

[1] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan

来源：

THROMBOSIS RESEARCH | 2014年 / 134卷 / 06期

关键词：

CHRONIC KIDNEY-DISEASE; ATRIAL-FIBRILLATION; RENAL-FUNCTION; STROKE; NEPHROPATHY; EXPRESSION; PLASMA; TRIAL;

D O I：

10.1016/j.thromres.2014.09.028

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1365 / 1367

页数：3

共 14 条

[1]

Preventing Stroke and Systemic Embolism in Renal Patients with Atrial Fibrillation: Focus on Anticoagulation [J].

Ahmad, Yousif ;

Lip, Gregory Y. H. .

BRAIN, STROKE AND KIDNEY, 2013, 179 :81-91

[2]

Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial [J].

Apostolakis, Stavros ;

Guo, Yuotao ;

Lane, Deirdre A. ;

Buller, Harry ;

Lip, Gregory Y. H. .

EUROPEAN HEART JOURNAL, 2013, 34 (46) :3572-3579

[3]

Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices [J].

Cairns, John A. .

CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) :1165-1172

[4]

Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes [J].

Chiarelli, F ;

Cipollone, F ;

Mohn, A ;

Marini, M ;

Iezzi, A ;

Fazia, M ;

Tumini, S ;

De Cesare, D ;

Pomilio, M ;

Pierdomenico, SD ;

Di Gioacchino, M ;

Cuccurullo, F ;

Mezzetti, A .

DIABETES CARE, 2002, 25 (10) :1829-1834

[5]

Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease [J].

Hart, Robert G. ;

Eikelboom, John W. ;

Brimble, K. Scott ;

McMurtry, M. Sean ;

Ingram, Alistair J. .

CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (07) :S71-S78

[6]

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial [J].

Hohnloser, Stefan H. ;

Hijazi, Ziad ;

Thomas, Laine ;

Alexander, John H. ;

Amerena, John ;

Hanna, Michael ;

Keltai, Matyas ;

Lanas, Fernando ;

Lopes, Renato D. ;

Lopez-Sendon, Jose ;

Granger, Christopher B. ;

Wallentin, Lars .

EUROPEAN HEART JOURNAL, 2012, 33 (22) :2821-2830

[7]

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression [J].

Ishibashi, Yuji ;

Matsui, Takanori ;

Ueda, Seiji ;

Fukami, Kei ;

Yamagishi, Sho-ichi .

CARDIOVASCULAR DIABETOLOGY, 2014, 13

[8]

New Oral Anticoagulants A Review of the Literature with Particular Emphasis on Patients with Impaired Renal Function [J].

Poulsen, Birgitte Klindt ;

Grove, Erik Lerkevang ;

Husted, Steen Elkjaer .

DRUGS, 2012, 72 (13) :1739-1753

[9]

Reinecke H, 2014, KIDNEY INT

[10]

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? [J].

Roldan, Vanessa ;

Marin, Francisco ;

Manzano-Fernandez, Sergio ;

Fernandez, Hermogenes ;

Gallego, Pilar ;

Valdes, Mariano ;

Vicente, Vicente ;

Lip, Gregory Y. H. .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) :956-960

← 1 2 →